About

Peter Villax is Chief Executive Officer at Hovione Technology. He joined Hovione in 1982 as a computer programmer, then switched to pharmaceutical development in 1990, soon becoming interested in pulmonary delivery and in the development of DPIs. In 2007 Hovione licensed TwinCaps® to Daiichi Sankyo for the delivery of Inavir®, becoming market leader in the influenza space in Japan.

He acquired significant experience as an inventor of devices, as a patent writer and as licensor of technology patents.

Contributions

PULMONARY

DRY POWDER INHALERS: TOWARDS EFFECTIVE, AFFORDABLE, SUSTAINABLE RESPIRATORY HEALTHCARE

João Ventura Fernandes and Peter Villax look at the trends shaping the development of dry powder inhalers, highlighting the need for a shift in industrial strategy towards effective, globally affordable, sustainable devices.

More contributions

PULMONARY

SCALING-UP FOR HIGH DOSE DELIVERY TO THE LUNGS

João Ventura Fernandes, Gonçalo Rebelo de Andrade and Peter Villax describe the scaling up of the currently marketed TwinCaps® inhaler into the new TwinMax™ design for high-dose delivery of challenging drug-alone formulations in single to short-term treatments and emergency situations.